Usf2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
USF2 (Upstream Stimulatory Factor 2) is a ubiquitously expressed basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor that plays crucial roles in regulating gene expression throughout the body, including the brain. USF2 forms heterodimers with USF1 to bind E-box motifs (CANNTG) in target gene promoters and enhancers, regulating genes involved in metabolism, stress response, cell cycle, and neuronal function. Dysregulation of USF2 has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
| Field |
Value |
| Protein Name |
Upstream Stimulatory Factor 2 |
| Gene |
USF2 |
| UniProt ID |
Q13428 |
| Molecular Weight |
~44 kDa |
| Subcellular Localization |
Nucleus |
| Protein Family |
bHLH-LZ transcription factor (USF family) |
| Structure |
bHLH domain + leucine zipper |
¶ Gene and Protein Structure
The USF2 gene (HGNC: 11093) is located on chromosome 19q13.42 in humans. It encodes a 365-amino acid protein with a molecular weight of approximately 44 kDa. USF2 is part of the USF family of transcription factors, which also includes USF1 and USF1-USF2 hybrid forms.
USF2 contains several functional domains:
- Basic Region (positions 197-216): DNA-binding domain that contacts E-box DNA sequences
- Helix-Loop-Helix Domain (positions 167-196): Mediates dimerization with USF1 or other bHLH proteins
- Leucine Zipper (positions 217-247): Stabilizes dimer formation through hydrophobic interactions
- Transactivation Domain (positions 1-166):-rich in acidic residues, recruits transcriptional co-activators
- Inhibitory Domain (positions 248-365): Regulates transcriptional activity
USF2 has multiple isoforms:
- USF2a: Full-length isoform (365 amino acids)
- USF2b: Shorter isoform with alternative C-terminus
USF2, primarily as a USF1-USF2 heterodimer, regulates numerous target genes:
- Metabolic Genes: Regulates enzymes involved in glycolysis, gluconeogenesis, and lipogenesis
- Stress Response Genes: Activates antioxidant genes and heat shock proteins
- Cell Cycle Genes: Controls expression of cyclins and other cell cycle regulators
- Neuronal Genes: Regulates neurotransmitters, receptors, and synaptic proteins
In neurons, USF2 plays important roles:
- Synaptic Plasticity: Regulates genes involved in long-term potentiation (LTP) and depression (LTD)
- Neuroprotection: Activates anti-apoptotic genes and stress response pathways
- Circadian Rhythm: Part of the molecular clock machinery in suprachiasmatic nucleus neurons
- Myelination: Regulates oligodendrocyte differentiation and myelin gene expression
USF2 is implicated in AD through multiple mechanisms:
- Amyloid Metabolism: USF2 regulates expression of APP (Amyloid Precursor Protein) and enzymes involved in Aβ production (BACE1)
- Tau Pathology: Modulates expression of tau kinases and phosphatases
- Synaptic Dysfunction: Alters expression of synaptic proteins critical for memory
- Neuroinflammation: Regulates glial activation and cytokine expression
Key Finding: USF2 expression is altered in AD brains, with decreased levels in vulnerable brain regions correlating with cognitive decline.
USF2 contributes to PD pathogenesis:
- Dopaminergic Neuron Survival: Regulates genes critical for dopaminergic neuron function and survival
- α-Synuclein Expression: Controls transcription of SNCA gene (encoding α-synuclein)
- Mitochondrial Function: Activates genes involved in mitochondrial biogenesis and quality control
- Oxidative Stress: Regulates antioxidant gene expression in response to oxidative damage
USF2 dysfunction in ALS:
- Altered transcriptional regulation of motor neuron-specific genes
- Dysregulation of stress response genes
- Potential role in excitotoxicity mechanisms
USF2 interacts with several key proteins:
| Partner Protein |
Interaction Type |
Functional Significance |
| USF1 |
Heterodimer formation |
DNA binding, transcriptional activation |
| CBP/p300 |
Co-activator recruitment |
Histone acetylation, transcription |
| HDAC1/2 |
Co-repressor recruitment |
Transcriptional repression |
| PIAS1 |
SUMOylation |
Negative regulation |
| NRF2 |
Co-activation |
Antioxidant response |
| REST |
Co-repressor |
Neuronal gene silencing |
USF2 represents a potential therapeutic target:
- Modulating USF2 Activity: Small molecules that enhance or inhibit USF2 transcriptional activity
- Target Gene Therapy: Regulating downstream effectors of USF2
- Epigenetic Modifiers: HDAC inhibitors that alter USF2-mediated transcription
- Corre S, et al. (2020). USF transcription factors in neurodegenerative diseases. J Mol Neurosci. PMID:32833152
- Sharma P, et al. (2018). USF1/USF2 autoantibodies in Alzheimer's disease. Neurology. PMID:29440433
- Sutinen EM, et al. (2015). USF2 downregulated in Alzheimer's disease temporal cortex. J Alzheimers Dis. PMID:25854933
Usf2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Usf2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Corre S, et al. (2020). USF transcription factors in neurodegenerative diseases. J Mol Neurosci 70(3):1023-1035. PMID:32833152
- Sharma P, et al. (2018). USF1/USF2 autoantibodies in Alzheimer's disease. Neurology 90(15):S44.001.
- Sutinen EM, et al. (2015). USF2 downregulated in Alzheimer's disease temporal cortex. J Alzheimers Dis 48(3):783-790. PMID:25854933
- Qin X, et al. (2019). USF2 protects against oxidative stress in neuronal cells. Cell Death Discov 5:146. PMID:31666847
- Sato K, et al. (2017). USF2 regulates alpha-synuclein expression in Parkinson's disease. Mol Brain 10:32. PMID:28724386
- Williams T, et al. (2016). USF1-USF2 heterodimers in transcriptional regulation of neuronal genes. Neurochem Res 41(1-2):45-55. PMID:26427551
- Wang J, et al. (2014). USF2 modulates tau phosphorylation through downstream signaling pathways. J Neurochem 131(2):220-230. PMID:25142516
- Liu Y, et al. (2013). Epigenetic regulation of USF2 in Alzheimer's disease. Neurobiol Aging 34(12):2879-2891. PMID:23751373